🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase I, single dose study to test two forms of pediatric ritlecitinib co...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2021-09-10
Trial ID
NCT05040295
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Recruiting
Location
Medical Dermatology Specialists
Start Date
2025-11-13
Trial ID
NCT07228390
Treatments Being Tested
This study is a secondary analysis of the Adelphi Real World Alopecia Areat...
Status
Completed
Location
Pfizer
Start Date
2025-02-03
Trial ID
NCT07200128
Treatments Being Tested
The introduction of Janus Kinase inhibitors (JAKi) seems to revolutionize t...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2024-07-29
Trial ID
NCT06573593
Treatments Being Tested
Alopecia could be subdivided into two main groups of diseases: non-scarring...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2022-12-15
Trial ID
NCT05549934
Treatments Being Tested
Alopecia areata (AA) is a chronic, relapsing T-cell mediated autoimmune dis...
Status
Completed
Location
Pfizer
Start Date
2025-12-22
Trial ID
NCT07226531
Treatments Being Tested
The purpose of this study is to compare if three forms of study medicine (c...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2024-02-01
Trial ID
NCT06172348
Treatments Being Tested
The purpose of this clinical trial is to learn about long-term safety and l...
Status
Recruiting
Location
California Dermatology & Clinical Research Institute
Start Date
2025-09-10
Trial ID
NCT07029828
Treatments Being Tested
This is a Phase 1, 2-period, multiple-dose, open-label, single fixed sequen...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2021-11-02
Trial ID
NCT05097716
Treatments Being Tested
Vitiligo affects approximately 1 to 2% of the global population and signifi...
Status
Recruiting
Location
CHu de Nice, Hôpital Archet
Start Date
2026-03-12
Trial ID
NCT07152626
Treatments Being Tested